Vertex Pharmaceuticals Inc (VRTX) stock
VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 15/3026% above fair value
$538.60−4.02 (-0.74%)
Close on Nov 13, 2026Market cap $136.51BP/E 31.4Yield –
Vertex Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Vertex Pharmaceuticals's market cap was $138.59B on Nov 11, 2026, against $110.12B a year earlier. Over the last 5 years it ranged from $56.26B to $141.59B, with a median of $108.42B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $138.59B | +20.4% |
| 2025 | Dec 31, 2025 | $115.13B | +10.9% |
| 2024 | Dec 31, 2024 | $103.79B | -1.1% |
| 2023 | Dec 29, 2023 | $104.91B | +41.5% |
| 2022 | Dec 30, 2022 | $74.11B | +31.7% |
| 2021 | Dec 31, 2021 | $56.26B | -8.5% |
| 2020 | Dec 31, 2020 | $61.49B | +9.2% |
| 2019 | Dec 31, 2019 | $56.33B | +33.0% |
| 2018 | Dec 31, 2018 | $42.36B | +11.9% |
| 2017 | Dec 29, 2017 | $37.87B | +107.2% |
| 2016 | Dec 30, 2016 | $18.27B | -40.9% |
| 2015 | Dec 31, 2015 | $30.91B | +8.3% |
| 2014 | Dec 31, 2014 | $28.54B | +64.4% |
| 2013 | Dec 31, 2013 | $17.36B | +91.5% |
| 2012 | Dec 31, 2012 | $9.06B | +30.9% |
| 2011 | Dec 30, 2011 | $6.92B | -2.7% |
| 2010 | Dec 31, 2010 | $7.11B | +18.1% |
| 2009 | Dec 31, 2009 | $6.02B | – |
See a number that looks wrong?